Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Elevated Blood Pressure
NCT03764020Phase 3Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, triple-blind trial in hypertension (HTN) comparing Melatonin Arm with Placebo Arm (2 arms). Primary endpoints: Systolic Blood Pressure at 3 weeks, Diastolic Blood Pressure at 3 weeks and 4 more. Status: unknown.
02
Drugs
melatonin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03764020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03764020.